Skip to content

Gyre Therapeutics, Inc. GYRE Gyre — General And Administrative Expense

Other segment segments

Gyre Pharmaceuticals
$4.76M+33.8%
All Other Segments
$6K+100%

Similar metrics at other companies

Alto Neuroscience logo
ANROReportable segment — G&A
$4.09M+34.4%
Solid Biosciences Inc. logo
SLDBInternal General And Administrative Expense — General And Administrative Expense
$3.87M+11.6%
Yext logo
YEXTReportable Segment — G&A
$16.36M+13.8%
Archer Aviation logo
ACHRG&A
$83.2M+106%
Ryan Specialty Holdings logo
RYANReporting Segment — G&A
$101.37M+9.9%
Beam Therapeutics logo
BEAMExternal General And Administrative Expenses — General And Administrative Expense
$13.37M+149%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s gyre — general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre — general and administrative expense?
Gyre Therapeutics, Inc. (GYRE) reported gyre — general and administrative expense of $2.46M in Q1 2026.
How has Gyre Therapeutics, Inc.'s gyre — general and administrative expense changed year-over-year?
Gyre Therapeutics, Inc.'s gyre — general and administrative expense increased by 76.0% year-over-year, from $1.4M to $2.46M.
What is the long-term trend for Gyre Therapeutics, Inc.'s gyre — general and administrative expense?
Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre — general and administrative expense has grown at a 18.3% compound annual growth rate (CAGR), from $5.21M to $7.29M.
What does gyre — general and administrative expense mean?
This includes the overhead costs required to support the segment's operations, such as executive salaries, legal fees, office rent, and other corporate support functions. It represents the fixed cost base necessary to maintain the business infrastructure. Investors monitor this to assess the company's operational discipline and scalability.